Braidwell »

Align Technology shares owned by Braidwell

Quarter-by-quarter ownership of Align Technology (ALGN) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Align Technology

Tip: Access up to 7 years of quarterly data

All positions including Align Technology held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Align Technology by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $40M 146k 274.00
2023-09-30 $38M 125k 305.32
2023-06-30 $79M 224k 353.64
2023-03-31 $69M 207k 334.14
2022-12-31 $46M 220k 210.90

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Align Technology

Vanguard Group
Jpmorgan Chase & Co
Wellington Management Company
Alliancebernstein
Polen Capital Management
Brown Advisory Holdings Incorporated
Investec Asset Management
Bank of New York Mellon
Citadel Advisors
Millennium Management
Norges Bank Investment Management
Allianz Asset Management
Bares Capital Management
Legal & General Group
Amundi

View all funds holding Align Technology